Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolio
Close

Siemens Healthineers AG (SHLG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
52.88 -1.16    -2.15%
17/05 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 50
  • Bid/Ask: 52.88 / 53.18
  • Day's Range: 52.88 - 54.06
Type:  Equity
Market:  Germany
ISIN:  DE000SHL1006 
S/N:  SHL100
Siemens Healthineers 52.88 -1.16 -2.15%

ETR:SHLG Financials

 
This summary provides an overview of the most significant critical numbers from each of the Siemens Healthineers AG financial reports, including theSiemens Healthineers AG income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the ETR:SHLG financials over time via breakdowns of their annual reports.

For the six months ended 31 March 2022, Siemens Healthineers AG revenues increased 34% to EUR10.53B. Net income applicable to common stockholders increased 19% to EUR1.05B. Revenues reflect Diagnostics segment increase of 33% to EUR3.21B, Imaging segment increase of 10% to EUR4.99B, United States segment increase of 54% to EUR3.51B, Europe,C.I.S.,Africa,Middle East (without Germany) segment increase of 27% to EUR2.89B.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

SHLG Income Statement & Profits

Gross margin TTM 37.5%
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Total Revenue 5460 5068 5164 5000
Gross Profit 2039 1907 1959 1921
Operating Income 760 692 622 672
Net Income 579 465 463 390

SHLG Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ 1.31
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Total Assets 43978 43116 41879 41549
Total Liabilities 27062 26158 25842 26242
Total Equity 16916 16958 16037 15307

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  9.19%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Period Length: 6 Months 3 Months 12 Months 9 Months
Cash From Operating Activities 1101 719 2933 2329
Cash From Investing Activities -383 -162 -14140 -13905
Cash From Financing Activities -1022 -603 11839 12149
Net Change in Cash -246 -14 666 580
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SHLG Price Commentary

Write your thoughts about Siemens Healthineers AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email